We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$79.9B
AUM Growth
+$16.7B
Cap. Flow
+$9.74B
Cap. Flow %
12.19%
Top 10 Hldgs %
13.34%
Holding
4,935
New
829
Increased
1,631
Reduced
1,587
Closed
796

Sector Composition

Rank Sector Weight
1 Healthcare 9.65%
2 Technology 8.5%
3 Financials 8.48%
4 Consumer Discretionary 7.65%
5 Industrials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLO
4001
Clough Global Opportunities Fund
GLO
$247M
$95K ﹤0.01%
+10,085
New +$93.4K
INFU icon
4002
InfuSystem Holdings
INFU
$199M
$95K ﹤0.01%
+11,153
New +$82.1K
USAS
4003
Americas Gold and Silver
USAS
$1.28B
$95K ﹤0.01%
+11,979
New +$85.5K
IVAC
4004
DELISTED
Intevac Inc
IVAC
$95K ﹤0.01%
13,449
-4,012
-23% -$23.5K
TKC icon
4005
Turkcell
TKC
$4.79B
$94K ﹤0.01%
+16,194
New +$92.4K
GRCE
4006
Grace Therapeutics
GRCE
$37.3M
$94K ﹤0.01%
+803
New +$79.3K
KZR
4007
DELISTED
Kezar Life Sciences
KZR
$92K ﹤0.01%
2,301
+795
+53% +$24.5K
GNCA
4008
DELISTED
Genocea Biosciences, Inc.
GNCA
$91K ﹤0.01%
43,883
-72,963
-62% -$173K
STGW icon
4009
Stagwell
STGW
$1.95B
$90K ﹤0.01%
+32,550
New +$87.7K
QTT
4010
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$89K ﹤0.01%
2,610
-3,079
-54% -$103K
MBRX icon
4011
Moleculin Biotech
MBRX
$15.5M
$88K ﹤0.01%
43
-52
-55% -$122K
GLMD icon
4012
Galmed Pharmaceuticals
GLMD
$4.05M
$87K ﹤0.01%
+83
New +$71.3K
ESTE
4013
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$87K ﹤0.01%
13,717
-2,807
-17% -$13.2K
VRDN icon
4014
Viridian Therapeutics
VRDN
$2.14B
$86K ﹤0.01%
11,993
-14,724
-55% -$151K
FSTX
4015
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$85K ﹤0.01%
13,517
-11,502
-46% -$146K
NVAX icon
4016
Novavax
NVAX
$1.22B
$83K ﹤0.01%
20,854
+6,932
+50% +$30.1K
SVRA icon
4017
Savara
SVRA
$1.08B
$81K ﹤0.01%
17,994
-71,938
-80% -$86.6K
FCRD
4018
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$81K ﹤0.01%
+12,887
New +$87K
VAL
4019
DELISTED
Valaris plc Class A Ordinary Share
VAL
$81K ﹤0.01%
+12,358
New +$60.2K
AEYE icon
4020
AudioEye
AEYE
$77.1M
$80K ﹤0.01%
17,116
-14,686
-46% -$62K
HCR
4021
DELISTED
Hi-Crush Inc. Common Stock
HCR
$80K ﹤0.01%
+91,114
New +$96.1K
RLGT icon
4022
Radiant Logistics
RLGT
$412M
$79K ﹤0.01%
14,233
-15,759
-53% -$85.2K
NSCO.WS
4023
CALL
DELISTED
Nesco Holdings, Inc. Warrants, exerciseable for Common Stock
NSCO.WS
$79K ﹤0.01%
+19,246
New +$10.6K
IRS
4024
IRSA Inversiones y Representaciones
IRS
$1.3B
$76K ﹤0.01%
10,580
-77,760
-88% -$446K
TUES
4025
DELISTED
Tuesday Morning Corp
TUES
$75K ﹤0.01%
40,468
-38,317
-49% -$61K

Similar funds

Millennium Management's Q4 2019 Portfolio in Review

As of Q4 2019, Millennium Management held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Millennium Management deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, down from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.

  • Millennium Management's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
  • Millennium Management's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
  • Millennium Management fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
  • Millennium Management's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
  • Millennium Management opened 829 new positions and closed 796 in Q4 2019.
  • Millennium Management's portfolio value rose 26% quarter-over-quarter to $79.9B.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.